glp-1 and cancer Glucagon-like peptide-1 receptor agonists risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials GLP-1s may reduce cancer risk
Description
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026
Walker says, Many inflammatory skin conditions are difficult to manage because the cause of these concerns goes deeper than the skin
Both can take longer if your provider recommends extended time at any dose level due to side effects
The medications are very effective at helping reduce food intake, but they do nothing for the underlying reasons you were reaching for food to begin with
Only sharing this to let yall know it also does not matter what you weigh or if you lose weight, another comment read
However, several concerns remain
